New RA drug JADE201 enters first human safety trial
NCT ID NCT07533955
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests a single injection of JADE201 in 36 adults with rheumatoid arthritis. The main goal is to check safety and how the body processes the drug. Participants receive either JADE201 or a placebo, and researchers monitor side effects and drug levels in the blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
JADE201
What this could lead to
If safe and effective, JADE201 could become a new treatment option to control rheumatoid arthritis symptoms and inflammation.
What could go wrong
This is a very early Phase 1 trial with only 36 people. The main goal is safety, not effectiveness. Many drugs fail at this stage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jade Clinical Site
RECRUITINGChisinau, Moldova, 2025, Moldova
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jade Clinical Site
RECRUITINGIvano-Frankivsk, Ukraine, 76018, Ukraine
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Jade Clinical Site
RECRUITINGKyiv, Ukraine, 02000, Ukraine
Contact Phone: •••-•••-•••• Email: •••••@•••••